Contact Us
Global
中国 Global

ACCURATE
Technology Platform of Organoid

in Scientific Research, Drug Development and Precision Medicine Run for Life

ACCURATE
Technology Platform of Organoid

in Scientific Research, Drug Development and Precision Medicine Run for Life

ACCURATE
Technology Platform of Organoid

in Scientific Research, Drug Development and Precision Medicine Run for Life
Technology Platform of Organoid in Scientific Research, Drug Development and Precision Medicine

Accurate International Biotechnology (Guangzhou) Co.,Ltd

is an innovative biotech-company that commits to the development and application of the organoid technology, and provides cutting edge platforms of organoid technology for biomedical investigation and exploration.

Guangdong Research Center of Organoid Engineering and Technology
National High-tech Enterprise
Enterprise with Speciality, Refinement, Differential and Innovation
Top 10 Enterprises in Chine Innovation & Entrepreneurship Competition
China Rising Star
Guangdong Provincial Key Laboratory
32000+
Organoid Cultures
5000+
Tumor Organoids Models
80+
Clinical Collaborators
70+
Products and Services
50+
Applied Patents
32000+ （）
Organoid Cultures
5000+ （）
Tumor Organoids Models
80+ （）
Clinical Collaborators
70+ （）
Products and Services
50+ （）
Applied Patents
Services and Products
Clinical Service
Provides accurate drug response results to assist oncologists selecting the most appropriate therapeutic regimes from standard-of-care drugs within the therapeutic time window. Thereby provides scientific data supporting clinical decision-making recommendation for oncologists and increases the survival chance of patients.
READ MORE
Services and Products
New Drug R&D Service
Provides one-stop solutions for drug discovery, preclinical- and clinical-research, and post-marketing research based on organoid technology platform.
READ MORE
Services and Products
Products
Include diverse organoid culture reagents, Organoid Microarray, Automated Liquid Handling Workstations and Organoid Drug Sensitivity Analytical Instruments.
READ MORE
NEWS
ACCURATE received the first ‘Enterprise with Speciality, Refinement, Differential and Innovation’ award in the Organoid industry!
Recently, the Guangzhou Federation of Industry and Commerce publicized the list of enterprises to be cultivated under the ‘Enterprise with Speciality, Refinement, Differential and Innovation’ private enterprise promotion plan in Guangzhou (the second batch). After comprehensive assessment and evaluation, ACCURATE has been recognized as the nurturing enterprise of Guangzhou ‘Enterprise with Speciality, Refinement, Differential and Innovation’ Private Enterprise Promotion Plan.
2022.11.18
ACCURATE received another 100 million yuan of financing, continuing to lead the organoid race!
Recently, ACCURATE announced the completion of a Pre-B round of financing of RMB 100 million. In the face of the epidemic and capital competition, ACCURATE has raised hundreds of millions of yuan in just two years, further consolidating its position as the leader of the organoid circuit! This round of financing is led by Fortune Capital, Guangzhou Jinkong Fund, GDD Industry Fund Investment Group, Wanlian Securities, Zhonghe Anke investment, Funway Capital and other original investment institutions continue to invest.
2022.10.28
Work with UM to explore the forefront of medicine and help Guangdong and Macao integrate Zhuhai-M.U.S.T. Science and Technology Research Institute - ACCURATE Organoid Joint Laboratory was inaugurated.
On September 23, 2022, the Guangdong Engineering and Technology Research Centre of Organoid Joint Laboratory of Zhuhai UM Science & Technology Research Institute - ACCURATE (hereinafter referred to as the "Joint Laboratory"), was officially inaugurated in the Creative Valley of Hengqin Deep Cooperation Zone. Liu Quanbao, Second-level Inspector of Science and Technology Bureau of Guangzhou Municipality, Liu Hui, Director of Economic Department of Liaison Office of the Central Government of Macao, Xie Yongqiang, Director of Economic and Technology Development Bureau of Macao, Huang Zhongjian, Deputy Cadre of Science and Technology Talent Department of Shenhe District Economic Development Bureau, Dai Jiong, Deputy Director of Zhuhai Science and Technology Innovation Bureau, Luo Fuzhi, Deputy Director of Zhuhai Health Bureau, Xu Jian, Vice President of University of Macau, Chen Guokai, Deputy Dean of UM School of Health Sciences, Huang Min, chairman of ACCURATE International, jointly unveiled the organoid joint laboratory.
2022.09.18
Co-innovation of frontier technology, alliance transformation set the standard China Pharmaceutical University -- ACCURATE Joint Organoid Laboratory was inaugurated.
On August 27, 2022, the opening ceremony of China Pharmaceutical University - Guangzhou ACCURATE International Organoid Joint Laboratory and the signing ceremony of ACCURATE International Professional Degree Graduate Student Practice Base was held in Nanjing. Kong Lingyi, Vice President of China Pharmaceutical University, Li Zhiyu, Director of Science and Technology Department, Xu Shuhong, Secretary of Party Committee of School of Basic Medicine and Clinical Pharmacy, Yang Yong, Dean of School of Basic Medicine and Clinical Pharmacy, Hu Rong, Vice Dean of School of Basic Medicine and Clinical Pharmacy, Qiang Lei, Vice Dean of School of Basic Medicine and Clinical Pharmacy, Huang Min, Chairman of the board of Directors and Zhu Zi, Vice President of Research and Development of ACCURATE Guangzhou Co., LTD., and representatives of Jiangsu ChiaTai Tianqing, Nanjing Robotrak, Nanjing TransThera, Jiangsu Aosaikang, Sanhome Pharmaceutical, Nanjing GeneLeap Biotech, Jiangsu CHAODIA, Nanjing COMTRUE Pharmaceutical, Nanjing ChiaTai Tianqing, Simsere Pharmaceutical, Guangzhou BT Gillion and other enterprises attended the ceremony.
2022.08.30
The milestone of precise medicine - The first publication of an expert consensus on the clinical application of organoid based drug sensitivity test!
On July 10, 2022, Expert Consensus on the Clinical Application of PDTO Drug Sensitivity Test was officially released by Tumor Markers Professional Committee of Chinese Anti-Cancer Association, Chinese Journal of Cancer Prevention and Control, Guangdong Research Center of Organoid Engineering and Technology, and Organogenic and Organon-on-a-chip Branch of Guangdong Precision Medicine Application Society.
2022.07.14
Message Board
Please select the type of service
attachment（Each file size limit is 20MB，file format jpg,png,gif,jpeg,bmp,pdf,mp3,mp4,doc,docx,csv,xls,xlsx,ppt,pptx,zip,7z,rar,tar）

Click or drag file to upload

Get code 60s